Inventor
GLENN JEFFREY S
US33 patents
⚠️ This page may combine multiple inventors who share the name “GLENN JEFFREY S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
11 patentsUS9926309B2Mar 27, 2018
Pi-kinase inhibitors with anti-infective activity
UNIV LELAND STANFORD JUNIOR5 citations82
US9309236B2Apr 12, 2016
PI-kinase inhibitors with broad spectrum anti-infective activity
UNIV LELAND STANFORD JUNIOR6 citations82
US11091472B2Aug 17, 2021
PI-kinase inhibitors with anti-infective activity
UNIV LELAND STANFORD JUNIOR3 citations71
US10428060B2Oct 1, 2019
PI-kinase inhibitors with anti-infective activity
UNIV LELAND STANFORD JUNIOR5 citations71
US11884657B2Jan 30, 2024
PI-kinase inhibitors with anti-infective activity
UNIV LELAND STANFORD JUNIOR0 citations61
US12522827B2Jan 13, 2026
Pan-genotypic agents against influenza virus and methods of using the same
UNIV LELAND STANFORD JUNIOR0 citations54
US11339392B2May 24, 2022
Pan-genotypic agents against influenza virus and methods of using the same
UNIV LELAND STANFORD JUNIOR0 citations54
US12472232B2Nov 18, 2025
Methods to treat viral infections
UNIV LELAND STANFORD JUNIOR0 citations53
US12415788B2Sep 16, 2025
PI4-kinase inhibitors and methods of using the same
UNIV LELAND STANFORD JUNIOR0 citations53
US7582428B2Sep 1, 2009
Methods and compositions for identifying anti-HCV agents
UNIV LELAND STANFORD JUNIOR0 citations47
US10597658B2Mar 24, 2020
Pan-genotypic agents against influenza virus and methods of using the same
UNIV LELAND STANFORD JUNIOR0 citations27
GLENN JEFFREY S
5 patentsUS8663648B2Mar 4, 2014
Agents for treatment of HCV and methods of use
GLENN JEFFREY S11 citations80
US8093353B2Jan 10, 2012
Agents for treatment of HCV and methods of use
GLENN JEFFREY S11 citations80
US5503973AApr 2, 1996
Method for inhibition of viral morphogenesis
GLENN JEFFREY S6 citations73
US8940730B2Jan 27, 2015
Methods and compositions of treating a Flaviviridae family viral infection
GLENN JEFFREY S1 citations49
US8871435B2Oct 28, 2014
Methods and compositions for identifying agents that inhibit an NS4B-mediated neoplastic cellular phenotype of HCV infected cells
GLENN JEFFREY S0 citations39
EIGER BIOPHARMACEUTICALS INC
4 patentsUS11311519B2Apr 26, 2022
Treatment of hepatitis delta virus infection
EIGER BIOPHARMACEUTICALS INC6 citations84
US10828283B2Nov 10, 2020
Treatment of hepatitis delta virus infection
EIGER BIOPHARMACEUTICALS INC10 citations82
US10076512B2Sep 18, 2018
Treatment of hepatitis delta virus infection
EIGER BIOPHARMACEUTICALS INC12 citations82
US11793793B2Oct 24, 2023
Treatment of hepatitis delta virus infection
EIGER BIOPHARMACEUTICALS INC3 citations71
EINAV SHIRIT
4 patentsUS9101628B2Aug 11, 2015
Methods and composition of treating a flaviviridae family viral infection
EINAV SHIRIT4 citations69
US9061010B2Jun 23, 2015
Methods of treating a Flaviviridae family viral infection and compositions for treating a Flaviviridae family viral infection
EINAV SHIRIT1 citations49
US8895598B2Nov 25, 2014
Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
EINAV SHIRIT1 citations49
US9149463B2Oct 6, 2015
Methods and compositions of treating a Flaviviridae family viral infection
EINAV SHIRIT0 citations38